These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 30962683)

  • 1. A comparison of methodologies for the real-time identification of hospitalized patients with acute exacerbations of COPD.
    Shah P; McWilliams A; Howard D; Roberge J
    Int J Chron Obstruct Pulmon Dis; 2019; 14():693-698. PubMed ID: 30962683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient characteristics associated with risk of first hospital admission and readmission for acute exacerbation of chronic obstructive pulmonary disease (COPD) following primary care COPD diagnosis: a cohort study using linked electronic patient records.
    Hunter LC; Lee RJ; Butcher I; Weir CJ; Fischbacher CM; McAllister D; Wild SH; Hewitt N; Hardie RM
    BMJ Open; 2016 Jan; 6(1):e009121. PubMed ID: 26801463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Multivariable Prediction Models for the Identification of Patients Admitted to Hospital with an Exacerbation of COPD and the Prediction of Risk of Readmission: A Retrospective Cohort Study using Electronic Medical Record Data.
    Fakhraei R; Matelski J; Gershon A; Kendzerska T; Lapointe-Shaw L; Kaneswaran L; Wu R
    COPD; 2023 Dec; 20(1):274-283. PubMed ID: 37555513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Association of Depressive Symptoms With Rates of Acute Exacerbations in Patients With COPD: Results From a 3-year Longitudinal Follow-up of the ECLIPSE Cohort.
    Yohannes AM; Mülerová H; Lavoie K; Vestbo J; Rennard SI; Wouters E; Hanania NA
    J Am Med Dir Assoc; 2017 Nov; 18(11):955-959.e6. PubMed ID: 28733182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of a Healthcare Utilization-Based Algorithm to Identify Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
    Mapel DW; Roberts MH; Sama S; Bobbili PJ; Cheng WY; Duh MS; Nguyen C; Thompson-Leduc P; Van Dyke MK; Rothnie KJ; Sundaresan D; Certa JM; Whiting TS; Brown JL; Roblin DW
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1687-1698. PubMed ID: 34135580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased vulnerability of COPD patient groups to urban climate in view of global warming.
    Hoffmann C; Hanisch M; Heinsohn JB; Dostal V; Jehn M; Liebers U; Pankow W; Donaldson GC; Witt C
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3493-3501. PubMed ID: 30498339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Identification and Cost of Acute Chronic Obstructive Pulmonary Disease Exacerbations in a United States Population Healthcare Claims Database.
    Stanford RH; Engel-Nitz NM; Bancroft T; Essoi B
    COPD; 2020 Oct; 17(5):499-508. PubMed ID: 32962447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between blood eosinophil percent and bacterial infection in acute exacerbation of chronic obstructive pulmonary disease.
    Choi J; Oh JY; Lee YS; Hur GY; Lee SY; Shim JJ; Kang KH; Min KH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():953-959. PubMed ID: 31190782
    [No Abstract]   [Full Text] [Related]  

  • 9. Phenotyping and outcomes of hospitalized COPD patients using rapid molecular diagnostics on sputum samples.
    Alotaibi NM; Chen V; Hollander Z; Leipsic JA; Hague CJ; Murphy DT; DeMarco ML; FitzGerald JM; McManus BM; Ng RT; Sin DD
    Int J Chron Obstruct Pulmon Dis; 2019; 14():311-319. PubMed ID: 30774328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuity of Care Assessment Within a Vertically Integrated Care Management Organization Before and After COPD-Related Exacerbations.
    Fuoco MJ; Mularski RA; Wu B; Moretz C; McBurnie MA; Stanford RH; Crawford P; Gratie D; Salas B
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2755-2767. PubMed ID: 34675501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute exacerbated COPD: room for improvement in key elements of care.
    Markun S; Franzen DP; Dalla Lana K; Beyer S; Wieser S; Hess T; Kohler M; Rosemann T; Senn O; Steurer-Stey C
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2969-2975. PubMed ID: 29066878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective audit of antimicrobial prescribing practices for acute exacerbations of chronic obstructive pulmonary diseases in a large regional hospital.
    Brownridge DJ; Zaidi STR
    J Clin Pharm Ther; 2017 Jun; 42(3):301-305. PubMed ID: 28251670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergency department management of acute exacerbations of chronic obstructive pulmonary disease: factors predicting readmission.
    Bartels W; Adamson S; Leung L; Sin DD; van Eeden SF
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1647-1654. PubMed ID: 29872284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of short term re-exacerbation in patients with acute exacerbation of chronic obstructive pulmonary disease.
    Liu D; Peng SH; Zhang J; Bai SH; Liu HX; Qu JM
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1265-73. PubMed ID: 26170655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of the ProPal-COPD tool to identify patients with COPD for proactive palliative care.
    Duenk RG; Verhagen C; Bronkhorst EM; Djamin RS; Bosman GJ; Lammers E; Dekhuijzen P; Vissers K; Engels Y; Heijdra Y
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2121-2128. PubMed ID: 28790815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of utilization- and symptom-defined COPD exacerbations in hospital- and population-recruited patients.
    Erdal M; Johannessen A; Eagan TM; Bakke P; Gulsvik A; Grønseth R
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2099-108. PubMed ID: 27621614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute exacerbation of chronic obstructive pulmonary disease: influence of social factors in determining length of hospital stay and readmission rates.
    Wong AW; Gan WQ; Burns J; Sin DD; van Eeden SF
    Can Respir J; 2008 Oct; 15(7):361-4. PubMed ID: 18949105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and Prognostic Value of Inflammatory Parameters Including Neopterin in the Setting of Pneumonia, COPD, and Acute Exacerbations.
    Pizzini A; Lunger F; Sahanic A; Nemati N; Fuchs D; Weiss G; Kurz K; Bellmann-Weiler R
    COPD; 2017 Jun; 14(3):298-303. PubMed ID: 28548632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of hospitalization stay in COPD exacerbations: the AECOPD-F score.
    Diamantea F; Kostikas K; Bartziokas K; Karakontaki F; Tsikrika S; Pouriki S; Polychronopoulos V; Karagiannidis N; Haniotou A; Papaioannou AI
    Respir Care; 2014 Nov; 59(11):1679-86. PubMed ID: 24962226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of medical expenditure with nebulized budesonide versus systemic corticosteroids in hospitalized patients with acute exacerbations of chronic obstructive pulmonary disease in China.
    Zhang J; Yao W; You X; Liu T; Liu Y
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1195-1207. PubMed ID: 31213797
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.